 - Unable or unwilling to discontinue use of any drug known to be a strong or moderate inhibitor or inducer of CYP3A4 prohibited inducers and inhibitors must be discontinued within 2 weeks prior to first dose of study drug; see section 11.2 Appendix B; unable or unwilling to discontinue use of any proton pump inhibitor; see section 11.2, Appendix B 